Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients

Digestive Diseases and Sciences

Volumn 51, Issue 1, 2006, Pages 161-167

  Rodríguez Torres, Maribel ^a,b,e   Rodríguez Orengo, Jose F ^d   Ríos Bedoya, Carlos F ^b   Fernandez Carbia, Alberto ^c   Salgado Mercado, Rosa ^a   Marxuach Cuétara, Acisclo M ^a  

^a Fundacion de Investigacion de Diego San Juan   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c University Pathologists   (Puerto Rico)

^d PONCE SCHOOL OF MEDICINE   (Puerto Rico)

^e Fundacion de Investigacion de Diego   (Puerto Rico)

Author keywords

AIDS; Colitis; Diarrhea; HAART; HIV; Mesalamine

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; MESALAZINE; PLACEBO;

ADULT; ARTICLE; CHRONIC DIARRHEA; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; COLON BIOPSY; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; CHRONIC DISEASE; COLITIS; COLONOSCOPY; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MESALAMINE; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 30844472690     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3102-6     Document Type: Article

References (48)

1. World Health Organization: Joint United Nations Programme on HIV/AIDS. AIDS epidemic update. Document 2-E-1, 2001, p 1
2. Tam HK, Zhang ZF, Jacobson LP, Margolick JB, Chmiel JS, Rinaldo C, Detels R: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98:916-922, 2002
3. Dore GJ, Li Y, McDonald A, Ree H, Kaldor JM, Kaldo JM: Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia. J Acquir Immune Defic Syndr 29:388-395, 2002
4. Selik R, Byers R, Dworkin M: Division of HIV/AIDS Prevention-Surveillance and Epidemiology, National Center for HIV. CDC. J Acquir Immune Defic Syndr 29:378-387, 2002
5. Bini EJ, Cohen J: Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea. Am J Gastroenterol 94(12):3553-3559, 1999
6. Janoff EN, Smith PD: Perspectives on gastrointestinal infections in AIDS. Gastroenterol Clin North Am 17:451-463, 1988
7. Lubeck DP Bennett CL, Mazonson PD, Fifer SK, Fries JF: Quality of life and health service use among HIV-infected patients with chronic diarrhea. J Acquir Immune Defic Syndr 6:478-484, 1993
8. Duran S, Spire B, Raffi F, Walter V, Bouhour D, Journot V, Cailleton V, Leport C, Moatti JP: Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2:38-45, 2001
9. Tetreault D, Chang E: Managing and treating. AIDS-related diarrhea. Adv Nurse Pract 6:55-56, 58-60, 1998
10. Knox TA, Spiegelman D, Skinner SC, Gorbach S: Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 95:3482-3489, 2000
11. Watson A, Samore MH, Wanke CA: Diarrhea and quality of life in ambulatory HIV-infected patients. Dig Dis Sci 41(9):1794-1800, 1996
12. Monkemuller KE, Wilcox CM: Investigation of diarrhea in AIDS. Can J Gastroenterol 14(11):933-940, 2000
13. Oldfield EC 3rd: Evaluation of chronic diarrhea in patients with human immunodeficiency virus infection. Rev Gastroenterol Disord 2(4):176-188, 2002
14. Weber R, Ledergerber B, Zbinden R, Altwegg M, Pfyffer GE, Spycher MA, Briner J, Kaiser L, Opravil M, Myenberger C, Flepp M: Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Arch Intern Med 159(13):1473-1480, 1999
15. Raines CP, Flexner C, Sun E, Heath-Chiozzi M, Lewis RH, Fields C, Deetz C, Apuzzo L, Eshleman SH, Jackson JB, Gallant JE: Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. J Acquir Immune Defic Syndr 25:322-328, 2000
16. Riddler SA, Havlir D, Squires KE, Kerr B, Lewis RH, Yeh K, Wynne LH, Zhong L, Peng Y, Deutsch P, Saah A: Coadministration of indinavir and nelfinavir in human immunodeficiency virus type 1-infected adults: safety, pharmacokinetics, and antiretroviral activity. Antimicrob Agents Chemother 46:3877-3882, 2002
17. Flexner C, Bartlett JG: Complications of HIV therapy. Hopkins HIV Rep 12(2):14-15, 2000
18. Guest JL, Ruffin C, Pschampa JM, DeSilva KE, Rimland D: Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy 24(6):727-735, 2004
19. Bode H, Schmidt W, Schulzke JD, Fromm M, Zippel T, Wahnschaffe U, Bendfeldt K, Riecken EO, Ullrich R: The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir but not indinavir impair the epithelial barrier in the human intestinal cell line HT-29/B6, AIDS 13:2595-2597, 1999
20. Hing MC, Goldschmidt C, Mathijs JM, Cunningham AL, Cooper DA: Chronic colitis associated with human immunodeficiency virus infection. Med J Aust 156:683-687, 1992
21. Kotler DP: Organ-specific manifestations of HIV infection. I. Gastrointestinal diseases. AIDS 7 (S1):S211-S213, 1993
22. Kotler DP: Gastrointestinal manifestations of human immunodeficiency virus infection. Adv Intern Med 40:197-242, 1995
23. Yoshida EM, Chan NH, Herrick RA, Amar JN, Sestak PM, Willoughby BC, Whittaker JS: Human immunodeficiency virus infection, the acquired immunodeficiency syndrome, and inflammatory bowel disease. J Clin Gastroenterol 23(1):24-28, 1996
24. Christ AD, Sieber CC, Cathomas G, Gyr K: Concomitant active Crohn's disease and the acquired immunodeficiency syndrome. Scand J Gastroenterol 31(7):733-735, 1996
25. Sharpstone DR, Duggal A, Gazzard BG: Inflammatory bowel disease in individuals seropositive for the human immunodeficiency virus. Eur J Gastroenterol Hepatol 8(6):575-578, 1996
26. Orenstein JM, Dieterich DT: The histopathology of 103 consecutive colonoscopy biopsies from 82 symptomatic patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 125:1042-1046, 2001
27. Jensen-Fangel S, Justesen US, Black FT, Pedersen C, Obel N: The use of calcium carbonate in nelfinavir-associated diarrhoea in HIV-1-infected patients. HIV Med 4(1):48-52, 2003
28. Turner MJ, Angel JB, Woodend K, Giguere P: The efficacy of calcium carbonate in the treatment of protease inhibitor-induced persistent diarrhea in HIV-infected patients. HIV Clin Trials 5(1):19-24, 2004
29. Huffman FG, Walgren ME: L-Glutamine supplementation improves nelfinavir-associated diarrhea in HIV-infected individuals. HIV Clin Trials 4(5):324-329, 2003
30. Bushen OY, Davenport JA, Lima AB, Piscitelli SC, Uzgiris AJ, Silva TM, Leite R, Kosek M, Dillingham RA, Girao A, Lima AA, Guerrant RL: Diarrhea and reduced levels of antiretroviral drugs: improvement with glutamine or alanyl-glutamine in a randomized controlled trial in northeast Brazil. Clin Infect Dis 38(12):1764-1770, 2004
31. Di Paolo MC, Paoluzi OA, Pica R, Iacopini F, Crispino P, Rivera M, Spera G, Paoluzi P: Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Dig Liver Dis 33:563-569, 2001
32. Gisbert JP, Gomollon F, Mate J, Pajares JM: Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci 47:471-488, 2002
33. Gordon S, Ameen V, Bagby B, Shahan B, Jhingran P, Carter E: Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy. Dig Dis Sci 48(7):1317-1323, 2003
34. Gineston JL, Sevestre H, Descombes P, Viot J, Sevenet F, Davion T, Dupas JL, Capron JP: Biopsies of the endoscopically normal rectum and colon: a necessity. Incidence of collagen colitis and microscopic colitis. Gastroenterol Clin Biol 13(4):360-363, 1989
35. Lee JH, Rhee PL, Kim JJ, Koh KC, Paik SW, Han JH, Ree HJ, Rhee JC: The role of mucosal biopsy in the diagnosis of chronic diarrhea: value of multiple biopsies when colonoscopic finding is normal or nonspecific. Korean J Intern Med 12(2):182-187, 1997
36. Le Berre N, Heresbach D, Kerbaol M, Caulet S, Bretagne JF, Chaperon J, Gosselin M, Ramee MP: Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol 48(8):749-753, 1995
37. Jenkins D, Goodall A, Drew K, Scott BB: What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens. J Clin Pathol 41(1):72-79, 1988
38. Fine KD, Seidel RH, Do K: The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 51(3):318-326, 2000
39. Shah RJ, Fenoglio-Preiser C, Bleau BL, Giannella RA: Usefulness of colonoscopy with biopsy in the evaluation of patients with chronic diarrhea. Am J Gastroenterol 96(4):1091-1095, 2001
40. Miquel Plaza J, Lopez SanRoman A, del Pozo D, Pena E, Bermejo F, Baleriola I, Moreira V, Garcia Plaza A: Evolution and treatment response in microscopic colitis. Gastroenterol Hepatol 24(9):433-439, 2001
41. De La Riva S, Betes MT, Duque JM, Angos R, Munoz Navas MA: Collagenous colitis and lymphocytic colitis: clinical and endoscopic findings. Rev Esp Enferm Dig 92(2):86-96, 2000
42. Rice AB: Pathology of drug-associated gastrointestinal disease. Br J Clin Pharmacol 56(5):477-182, 2003
43. Makins R, Ballinger A: Gastrointestinal side effects of drugs. Expert Opin Drug Saf 2(4):421-129, 2003
44. Shepherd NA: Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 44(9):726-733, 1991
45. Faucheron JL, Parc R: Non-steroidal anti-inflammatory drug-induced colitis. Int J Colorectal Dis 11(2):99-101, 1996
46. Tysk C: Drug-induced enterocolitis. Important differential diagnosis in the investigation of diarrhea and intestinal hemorrhage. Lakartidningen 97(21):2606-2610, 2000
47. Chassany O, Michaux A, Bergmann JF : Drug-induced diarrhoea. Drug Saf 22(1):53-72, 2000
48. Appleyard CB, Hernandez G, Rios-Bedoya CF: Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 10(2):106-111, 2004